Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="519436.fig.001a" src="https://static.hindawi.com/articles/pc/volume-2013/519436/figures/519436.fig.001a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>  Galectins types</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="519436.fig.001b" src="https://static.hindawi.com/articles/pc/volume-2013/519436/figures/519436.fig.001b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b> Extracellular galectins-glycans interactions</td></tr></table></td></tr></table>

<table>Interactions of galectins with extracellular glycoconjugates.</table>

Prostate Cancer

fig1

Figure 1

Figure 1: Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers 